Denis R, Felix M, Mejia D, Hobbs M, Alvarez P, Casadesus D
Cureus. 2024; 16(2):e55077.
PMID: 38550497
PMC: 10977937.
DOI: 10.7759/cureus.55077.
Kalisvaart G, Den Berghe T, Grootjans W, Lejoly M, Huysse W, Bovee J
Skeletal Radiol. 2023; 53(2):319-328.
PMID: 37464020
PMC: 10730632.
DOI: 10.1007/s00256-023-04402-8.
Baidya Kayal E, Bakhshi S, Kandasamy D, Sharma M, Khan S, Kumar V
J Transl Med. 2022; 20(1):625.
PMID: 36575510
PMC: 9795762.
DOI: 10.1186/s12967-022-03838-1.
Cederberg K, Iyer R, Chaturvedi A, McCarville M, McDaniel J, Sandberg J
Pediatr Blood Cancer. 2022; 70 Suppl 4:e30000.
PMID: 36250990
PMC: 10661611.
DOI: 10.1002/pbc.30000.
Theruvath A, Rashidi A, Nyalakonda R, Avedian R, Steffner R, Spunt S
Pediatr Radiol. 2021; 51(13):2521-2529.
PMID: 34410452
PMC: 8602726.
DOI: 10.1007/s00247-021-05156-y.
Pediatric skeletal diffusion-weighted magnetic resonance imaging, part 2: current and emerging applications.
Chaturvedi A
Pediatr Radiol. 2021; 51(9):1575-1588.
PMID: 34018037
DOI: 10.1007/s00247-021-05028-5.
Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
Habre C, Dabadie A, Loundou A, Banos J, Desvignes C, Pico H
Pediatr Radiol. 2021; 51(9):1714-1723.
PMID: 33877417
PMC: 8363524.
DOI: 10.1007/s00247-021-05037-4.
Extraskeletal Ewing sarcoma: Diagnosis, management and prognosis.
Abboud A, Masrouha K, Saliba M, Haidar R, Saab R, Khoury N
Oncol Lett. 2021; 21(5):354.
PMID: 33747211
PMC: 7967932.
DOI: 10.3892/ol.2021.12615.
SLIC-supervoxels-based response evaluation of osteosarcoma treated with neoadjuvant chemotherapy using multi-parametric MR imaging.
Baidya Kayal E, Kandasamy D, Sharma R, Sharma M, Bakhshi S, Mehndiratta A
Eur Radiol. 2020; 30(6):3125-3136.
PMID: 32086578
DOI: 10.1007/s00330-019-06647-1.
Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
Liu C, Xi Y, Li M, Jiao Q, Zhang H, Yang Q
Korean J Radiol. 2019; 20(5):801-811.
PMID: 30993931
PMC: 6470081.
DOI: 10.3348/kjr.2018.0453.
The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma.
Haveman L, Ranft A, Vd Berg H, Smets A, Kruseova J, Ladenstein R
Cancer Med. 2019; 8(3):1086-1094.
PMID: 30790456
PMC: 6434194.
DOI: 10.1002/cam4.2002.
Atypical localization of intraosseous angioleiomyoma in the rib of a pediatric patient: a case report.
Djuricic G, Milosevic Z, Radovic T, Milcanovic N, Djukic P, Radulovic M
BMC Med Imaging. 2018; 18(1):54.
PMID: 30567503
PMC: 6300016.
DOI: 10.1186/s12880-018-0297-x.
Recurrent Follicular Dendritic Cell Sarcoma of the Parotid Gland Imaged with 18F-FDG PET/CT.
Makis W, Hudson E, Chiu B
Nucl Med Mol Imaging. 2017; 51(4):354-356.
PMID: 29242731
PMC: 5721082.
DOI: 10.1007/s13139-016-0465-2.
Analysis of imaging characteristics of primary malignant bone tumors in children.
Sun Y, Liu X, Pan S, Deng C, Li X, Guo Q
Oncol Lett. 2017; 14(5):5801-5810.
PMID: 29113210
PMC: 5661490.
DOI: 10.3892/ol.2017.6939.
[Postoperative and posttherapeutic changes after primary bone tumors : What's important for radiologists?].
Grieser T, Nobauer-Huhmann I
Radiologe. 2017; 57(11):938-957.
PMID: 28986639
DOI: 10.1007/s00117-017-0304-1.
How PET/MR Can Add Value For Children With Cancer.
Daldrup-Link H
Curr Radiol Rep. 2017; 5(3).
PMID: 28695063
PMC: 5501255.
DOI: 10.1007/s40134-017-0207-y.
Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?.
Klenk C, Gawande R, Tran V, Leung J, Chi K, Owen D
J Nucl Med. 2015; 57(1):70-7.
PMID: 26471690
PMC: 4703553.
DOI: 10.2967/jnumed.115.161646.
Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzala M
Clin Transl Oncol. 2015; 18(2):189-95.
PMID: 26250765
DOI: 10.1007/s12094-015-1351-6.
Magnetic resonance guided high-intensity focused ultrasound ablation of musculoskeletal tumors.
Avedian R, Gold G, Ghanouni P, Pauly K
Curr Orthop Pract. 2015; 22(4):303-308.
PMID: 26120376
PMC: 4479407.
DOI: 10.1097/BCO.0b013e318220dad5.
Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
Mullen J, Hornicek F, Harmon D, Raskin K, Chen Y, Szymonifka J
Cancer. 2014; 120(23):3676-82.
PMID: 25081640
PMC: 4239184.
DOI: 10.1002/cncr.28945.